Dr Devi Shetty, Kiran Mazumdar Shaw inaugurated 10 bedded BMT unit at Mazumdar Shaw Medical Centre, Narayana Health City

Published On 2023-02-04 09:45 GMT   |   Update On 2023-02-04 09:45 GMT

Bengaluru: With a vision to strengthen its presence in cancer care solutions in Karnataka region, Dr. Devi Shetty, Chairman & Executive Director, Narayana Health and Kiran Mazumdar Shaw, Executive Chairperson of Biocon Limited and Biocon Biologics Limited inaugurated a new Bone Marrow Transplant (BMT) Unit at Mazumdar Shaw Medical Centre, Narayana Health City on February 3. The event was...

Login or Register to read the full article

Bengaluru: With a vision to strengthen its presence in cancer care solutions in Karnataka region, Dr. Devi Shetty, Chairman & Executive Director, Narayana Health and Kiran Mazumdar Shaw, Executive Chairperson of Biocon Limited and Biocon Biologics Limited inaugurated a new Bone Marrow Transplant (BMT) Unit at Mazumdar Shaw Medical Centre, Narayana Health City on February 3. 

The event was also graced by Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Health and Dr. Sharat Damodar, Chairman - Oncology Services & Clinical Director – MSMC, Narayana Health. With the launch, BMT Unit has strengthened its capacity to 34 beds by adding 10 new beds. Furthermore, the inauguration was attended by 35 cancer survivors to raise awareness about cancer, importance of early detection and the latest treatment modalities.

The new unit aims to offer patients from Bengaluru, Karnataka state and nearby areas an easy access to qualified international standards of cancer care for bone marrow transplants. The unit will boost of CAR-T Cell Therapy & Immunotherapy and has proficient medical staff including of haemato-oncologists, BMT physicians and nursing staff.

BMT is an effective treatment modality for cancerous conditions like acute and chronic Myeloid and Lymphoblastic Leukemia, Hodgkin’s and Non-hodgkin’s Lymphoma, Myeloproliferative Neoplasms, Primary Myelofibrosis and Multiple Myeloma. It is also a preferred form of treatment for blood disorders like Aplastic anaemia, Immunodeficiency disorders, Congenital storage disorders, Congenital errors of metabolism and Haemoglobinopathies such as Thalassemia and Sickle Cell Anaemia.

Earlier, the leading healthcare chain had added another feather to it illustrious cap by successfully treating 2000 patients through Bone Marrow Transplant in October 2022, which gave them the distinction of being the first healthcare provider in the country to have performed 2000 Bone Marrow Transplants. Launch of this new unit is a testimony to the commitment of Narayana Health in its fight against cancer.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News